[Indirect causes of maternal deaths (except stroke, cardiovascular diseases and infections) in France 2013-2015].

Morts maternelles de causes indirectes (hors AVC, maladies cardiovasculaires et infections) en France 2013–2015.
Breast cancer Cancer du sein Chronic diseases Consultation préconceptionnelle Maladies chroniques Maternal mortality Mortalité maternelle Prepregnancy consultation

Journal

Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 9 11 2020
medline: 25 11 2021
entrez: 8 11 2020
Statut: ppublish

Résumé

Maternal deaths from indirect obstetric causes are the result of a pre-existing disease or condition that appeared during pregnancy without obstetric causes, but which was aggravated by the physiological effects of pregnancy. Twenty-six deaths from indirect causes related to a pre-existing pathology, excluding disease of the circulatory system or infection, were analysed by the committee of experts. Pre-existing pathology during pregnancy was documented in 13 women (asthma, n=3, genetic diseases, n=3, previous breast cancer, n=2, major sickle cell syndrome, n=2, epilepsy, n=1 and brain tumour, n=1). In 13 women, the pathology was not known before pregnancy (breast cancer, n=6, brain tumours, n=3, uterine sarcoma, n=1, cervical cancer, n=1, malignant melanoma, n=1 and acute myeloid leukaemia, n=1). For 16 women (61%), the death is related to a neoplastic pathology. Although the majority were considered inevitable for 11/16 women, 5 deaths were considered possibly preventable, the main preventable factor being a delay in diagnosis, and/or a delay in starting a specific treatment. For 10 women, the death is related to a chronic non-neoplastic pathology, known before pregnancy for 9 women, judged most often as possibly preventable, the main preventable factor being the failure of the medical team or the patient to take the pathology and/or its treatment into account. A preconception medical consultation with a specialist should be recommended to all patients with pre-existing disease. A clinical examination of the breasts is strongly recommended at the first visit and then during pregnancy.

Identifiants

pubmed: 33161193
pii: S2468-7189(20)30337-8
doi: 10.1016/j.gofs.2020.11.015
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

fre

Sous-ensembles de citation

IM

Pagination

83-88

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

V Le Guern (V)

Médecine interne, centre de référence national pour les maladies auto-immunes rares d'Île-de-France, hôpital Cochin, AP-HP, 27, rue de Faubourg Saint-Jacques, 75014 Paris, France. Electronic address: veronique.le-guern@aphp.fr.

M Rossignol (M)

Département d'anesthésie-réanimation et SMUR, hôpital Lariboisière, AP-HP, 2, rue Ambroise-Paré, 75465 Paris, France.

A Proust (A)

Département de gynécologie obstétrique, hôpital privé d'Antony, 1, rue Velpeau, 92160 Antony, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH